leuprolide acetate
ItalyDrugs containing this active substance
-
It is used to treat hormone-dependent prostate cancer in adult men, both in the metastatic stage and in cases of high-risk non-metastatic disease (the latter in combination with radiotherapy).
Form: solution for injection, powder and solvent
Active substance Dosage leuprolide acetate - ATC: L02AE02
Manufacturer: RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
-
It is used for the symptomatic treatment of advanced, hormone-dependent prostate cancer (prostate carcinoma).
Form: implant
Active substance Dosage leuprolide acetate - ATC: L02AE02
Manufacturer: SANDOZ S.P.A.
-
Politrate is prescribed for several treatments: palliative treatment of advanced prostate cancer in men; treatment of endometriosis and uterine fibroids (for a period of up to six months); treatment of breast cancer in women in pre- and perimenopause; preservation of ovarian function in premenopausal women undergoing chemotherapy; and the treatment of central precocious puberty in children.
Form: powder and solvent for preparation of suspension for injection, prolonged release
Active substance Dosage leuprolide acetate - ATC: L02AE02
Manufacturer: SOPHOS BIOTECH S.R.L.